{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:01:05Z","timestamp":1791115265281,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T00:00:00Z","timestamp":1329350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031810","type":"journal-article","created":{"date-parts":[[2012,2,16]],"date-time":"2012-02-16T17:26:39Z","timestamp":1329413199000},"page":"e31810","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":219,"title":["Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa"],"prefix":"10.1371","volume":"7","author":[{"given":"Robert","family":"Sabat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akewit","family":"Chanwangpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylke","family":"Schneider-Burrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Metternich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kokolakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Kurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Sterry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions.","volume":"35","author":"GB Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.","volume":"59","author":"JE Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1610-0387.2007.06492.x","article-title":"Acne inversa.","volume":"6","author":"D Meixner","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review.","volume":"60","author":"A Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae.","volume":"164","author":"M von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1600-0625.2009.00915.x","article-title":"Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis.","volume":"19","author":"M von Laffert","year":"2010","journal-title":"Exp Dermatol"},{"key":"ref7","article-title":"Psychosocial Impact of Hidradenitis Suppurativa: A Qualitative Study.","author":"S Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa.","volume":"90","author":"L Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1524-4725.2010.01763.x","article-title":"Surgical treatment of hidradenitis suppurativa: experiences and recommendations.","volume":"36","author":"A Bieniek","year":"2010","journal-title":"Dermatol Surg"},{"key":"ref10","article-title":"Mild to moderate hidradenitis suppurativa treated with local excision and primary closure.","author":"DC van Rappard","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa.","volume":"26","author":"R Rompel","year":"2000","journal-title":"Dermatol Surg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1365-4632.2010.04638.x","article-title":"Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.","volume":"49","author":"M Arenbergerova","year":"2010","journal-title":"Int J Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.","volume":"219","author":"G Gener","year":"2009","journal-title":"Dermatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.","volume":"62","author":"A Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1610-0387.2008.06918.x","article-title":"Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.","volume":"7","author":"V Harde","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.","volume":"89","author":"P Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.","volume":"158","author":"JR Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"H Kurzen","year":"2008","journal-title":"Exp Dermatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa.","volume":"186","author":"K Wolk","year":"2011","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cytogfr.2010.11.001","article-title":"IL-10 family of cytokines.","volume":"21","author":"R Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cytogfr.2010.08.001","article-title":"IL-20: biological functions mediated through two types of receptor complexes.","volume":"21","author":"UM Wegenka","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cytogfr.2010.08.002","article-title":"Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection.","volume":"21","author":"E Witte","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues.","volume":"21","author":"K Wolk","year":"2004","journal-title":"Immunity"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","article-title":"Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.","volume":"196","author":"CP Chung","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis.","volume":"32","author":"T Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.","volume":"157","author":"P Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/archinte.165.22.2644","article-title":"Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.","volume":"165","author":"SG Wannamethee","year":"2005","journal-title":"Arch Intern Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.","volume":"112","author":"PW Wilson","year":"2005","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe.","volume":"359","author":"T Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.","volume":"288","author":"HM Lakka","year":"2002","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.","volume":"161","author":"K Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"ref33","article-title":"Psoriasis - a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives.","author":"WH Boehncke","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000111512","article-title":"Association between psoriasis and the metabolic syndrome. A cross-sectional study.","volume":"216","author":"AD Cohen","year":"2008","journal-title":"Dermatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis.","volume":"55","author":"AL Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref36","article-title":"Prevalence of the Metabolic Syndrome in Psoriasis: Results From the National Health and Nutrition Examination Survey, 2003\u20132006.","author":"TJ Love","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis.","volume":"296","author":"JM Gelfand","year":"2006","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imlet.2010.02.008","article-title":"Effects of hypoxia and\/or lack of glucose on cellular energy metabolism and cytokine production in stimulated human CD4+ T lymphocytes.","volume":"131","author":"R Dziurla","year":"2010","journal-title":"Immunol Lett"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1002\/eji.200939687","article-title":"The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis.","volume":"39","author":"K Wolk","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis.","volume":"36","author":"K Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","article-title":"The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.","volume":"178","author":"SM Sa","year":"2007","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T14:46:33Z","timestamp":1540305993000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031810"}},"subtitle":[],"editor":[{"given":"Holger","family":"Bruggemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,16]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031810","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13945971.15401074","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,16]]}}}